Does CARFILZOMIB Cause Soft tissue infection? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Soft tissue infection have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.1% of all adverse event reports for CARFILZOMIB.
18
Reports of Soft tissue infection with CARFILZOMIB
0.1%
of all CARFILZOMIB reports
7
Deaths
10
Hospitalizations
How Dangerous Is Soft tissue infection From CARFILZOMIB?
Of the 18 reports, 7 (38.9%) resulted in death, 10 (55.6%) required hospitalization, and 2 (11.1%) were considered life-threatening.
Is Soft tissue infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARFILZOMIB. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Soft tissue infection?
METHOTREXATE (129)
PREDNISONE (105)
CYCLOPHOSPHAMIDE (98)
RITUXIMAB (98)
MYCOPHENOLATE MOFETIL (81)
VINCRISTINE (76)
DEXAMETHASONE (70)
TACROLIMUS (68)
DOXORUBICIN (64)
CYCLOSPORINE (53)
Which CARFILZOMIB Alternatives Have Lower Soft tissue infection Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL